These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2975829)

  • 1. [Kinetic, cytogenetic, morphometric characteristics and DNA content of transitional cell bladder carcinomas].
    Matturri L; Lavezzi AM
    Arch Ital Urol Nefrol Androl; 1988 Mar; 60(1):19-28. PubMed ID: 2975829
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
    Nenning H; Rassler J; Minh DH; Stolzenburg JU
    Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
    Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphometry of bladder carcinoma: definition of a new variable.
    Sowter C; Sowter G; Slavin G; Rosen D
    Anal Cell Pathol; 1990 Jul; 2(4):205-13. PubMed ID: 2275868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear volume in transitional cell tumours. An assessment of its prognostic and biological impact.
    Nielsen K
    Dan Med Bull; 1991 Aug; 38(4):304-16. PubMed ID: 1914530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Establishment of epithelial cell line TBC-27 from a human bladder transitional cell carcinoma and its biological characteristics].
    Liu CJ; Ma TX; Wang ZQ; Chang JW; Liu XB; Sui ZF; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):427-9, 21. PubMed ID: 3452540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
    Reid LM; Leav I; Kwan PW; Russell P; Merk FB
    Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar organizer region in transitional cell carcinoma of the bladder.
    Pisac VP; Krizanac S; Andelinović S
    Acta Med Croatica; 1997; 51(2):83-6. PubMed ID: 9204592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent chromosome alterations in transitional cell bladder carcinomas.
    Matturri L; Lavezzi AM
    Eur J Histochem; 1992; 36(2):177-86. PubMed ID: 1380851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
    Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
    Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of blood groups and transitional cell carcinoma of the bladder.
    Kirkali Z; Eryigit M
    Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic pattern of human urinary transitional cell carcinoma.
    Lavezzi AM; Costa A; Milesi M; Matturri L
    Basic Appl Histochem; 1986; 30(2):239-42. PubMed ID: 3741320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of human chorionic gonadotropin in tumors of the urinary bladder.
    Yamase HT; Wurzel RS; Nieh PT; Gondos B
    Ann Clin Lab Sci; 1985; 15(5):414-7. PubMed ID: 3904591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural classification of tumors of the urinary bladder. Its correlation to clinical course and morphological features under light microscopy].
    Nagayama T; Miyauchi T; Kuwahara T; Nakajima Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1890-5. PubMed ID: 6535019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Argentophilic nucleolar organizers and prognosis for patients with surface and locally advanced transitional cell cancer of the urinary bladder].
    Korneev IA
    Urologiia; 2005; (1):5-9. PubMed ID: 15776823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma].
    Radulović P; Pavić I; Marusić Z; Perić-Balja M; Znaor A; Kraus O; Kruslin B
    Lijec Vjesn; 2008; 130(1-2):1-3. PubMed ID: 18589634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.